NCT04009707

Brief Summary

The objective of this study is therefore to compare the results obtained with these two screening tests, using as gold standard the results obtained by the battery of neuropsychological reference tests.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 2, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 1, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 5, 2019

Completed
Last Updated

December 3, 2025

Status Verified

July 1, 2019

Enrollment Period

1.2 years

First QC Date

July 1, 2019

Last Update Submit

November 25, 2025

Conditions

Alcohol Use Disorder

Keywords

MoCABEARNI

Outcome Measures

Primary Outcomes (2)

  • sensitivity

    comparison of the sensitivity of the 2 tests against the gold standard

    Day 1 (only 1 time)

  • specificity

    comparison of the specificity of the 2 tests against the gold standard

    Day 1 (only 1 time)

Study Arms (1)

patients with alcool use desorders

Patient cared for in the addictology department of the University Hospital of Nîmes

Other: MoCA (Montreal Cognitive Assessment) testOther: BEARNI (Brief Evaluation of Alcohol Related Neuropsychological Impairment) Test

Interventions

MoCA (Montreal Cognitive Assessment) testOTHER

the MoCA questionnaire is used to assess cognitive disorders

patients with alcool use desorders
BEARNI (Brief Evaluation of Alcohol Related Neuropsychological Impairment) TestOTHER

This questionnaire is used to assess cognitive disorders

patients with alcool use desorders

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with alcoo use desorder

You may qualify if:

  • patients with alcoo use desorder
  • Patient cared for in the addictology department of the University Hospital of Nîmes

You may not qualify if:

  • refusal to use the data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Nîmes

Nîmes, 30029, France

Location

Related Publications (1)

  • Pelletier S, Alarcon R, Ewert V, Forest M, Nalpas B, Perney P. Comparison of the MoCA and BEARNI tests for detection of cognitive impairment in in-patients with alcohol use disorders. Drug Alcohol Depend. 2018 Jun 1;187:249-253. doi: 10.1016/j.drugalcdep.2018.02.026. Epub 2018 Apr 10.

    PMID: 29684893RESULT

MeSH Terms

Conditions

Alcoholism

Interventions

Mental Status and Dementia TestsEthanol

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Neuropsychological TestsPsychological TestsBehavioral Disciplines and ActivitiesAlcoholsOrganic Chemicals

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 1, 2019

First Posted

July 5, 2019

Study Start

November 2, 2017

Primary Completion

December 31, 2018

Study Completion

December 31, 2018

Last Updated

December 3, 2025

Record last verified: 2019-07

Locations

FR(1)